University of Cambridge > Talks.cam > Cambridge Science Summer School 2012 > The rise of antibody pharmaceuticals and their future

The rise of antibody pharmaceuticals and their future

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Phil Brereton.

Sir Greg Winter, Ph.D., FRS , (Master, Trinity College, University of Cambridge) is a British biochemist and a pioneer of therapeutic monoclonal antibodies who invented techniques to humanise antibodies using phage display for therapeutic uses. He founded Cambridge Antibody Technology (acquired by Astrazeneca in 2006 for £702m) and Bicycle Therapeutics and is on the Scientific Advisory Board of Covagen.

This talk is part of the Cambridge Science Summer School 2012 series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

© 2006-2024 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity